Theragnostics Opens U.S. Headquarters in Boston, Massachusetts
08/24/2017
Under the agreement, Theragnostics will distribute select ROTOP products in the U.S., Canada, Australia and New Zealand. In addition, ROTOP will manufacture GalliProst, Theragnostics' lead imaging candidate, and other agents in development, with distribution rights in the European Union and Switzerland.
Theragnostics' new headquarters is located in the historic Charlestown section of Boston, with close access to the region's prestigious teaching hospitals and global biotechnology hub. Products are expected to be available in the U.S. beginning September 1, 2017.
"Our relationship with ROTOP reflects our mission to serve the nuclear medicine community by delivering precisely targeted imaging and therapy agents for cancer patients and others," said Patrick Donahue, CEO, Theragnostics, Inc.
"It also supports our strategy to build revenue alongside the clinical development of our proprietary Galli® platform, which we believe will expand the power of PET imaging for thousands of physicians,” he added.
Project Announcements
Dana Canada Corporation Expands Oakville-Cambridge, Ontario, Canada, Operations
12/04/2023
Sparta Metal Processing Expands White County, Tennessee, Operations
12/01/2023
Walinga USA Expands Wayland, Michigan, Operations
12/01/2023
Amkor Technology Plans Peoria, Arizona, Advanced Packaging-Test Facility
12/01/2023
Dai Nippon Printing Plans Linwood, North Carolina, Lithium-ion Manufacturing Operations
11/29/2023
Axle Logistics Expands Knoxville, Tennessee, Operations
11/29/2023
Most Read
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
The Rise of Mid-Size U.S. Cities: The Industrial Development Boom
Q3 2023
-
Front Line: Brownfields Offer Redevelopment Opportunities
Q4 2023
-
2023 Top States Commentary: Top-Ranked States Have What It Takes to Win Mega Projects
Q3 2023
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
2023 Top States Workforce Development Programs
Q3 2023
-
Immigration: A Potential Fix for Labor Shortages?
Workforce Q4 2023